federal_register: 2024-26399
Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API
This data as json
| document_number | title | type | abstract | publication_date | pub_year | pub_month | html_url | pdf_url | agency_names | agency_ids | excerpts |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024-26399 | Patient-Focused Drug Development: Workshop To Discuss Methodologic and Other Challenges Related to Patient Experience Data; Public Workshop; Request for Comments | Notice | The Food and Drug Administration (FDA, the Agency, or we) is announcing the following virtual public workshop entitled "Patient- Focused Drug Development: Workshop to Discuss Methodologic and Other Challenges Related to Patient Experience Data." The purpose of the public workshop is to discuss methodological challenges related to patient experience data, and other areas of greatest interest or concern to public stakeholders. | 2024-11-14 | 2024 | 11 | https://www.federalregister.gov/documents/2024/11/14/2024-26399/patient-focused-drug-development-workshop-to-discuss-methodologic-and-other-challenges-related-to | https://www.govinfo.gov/content/pkg/FR-2024-11-14/pdf/2024-26399.pdf | Health and Human Services Department; Food and Drug Administration | 221,199 | The Food and Drug Administration (FDA, the Agency, or we) is announcing the following virtual public workshop entitled "Patient- Focused Drug Development: Workshop to Discuss Methodologic and Other Challenges Related to Patient Experience Data." The... |